What does Avalon Ventures invest in?
Avalon Ventures invests most often at Series A and Series B (70% of the rounds on record), in sectors such as Life Science and Information Technology.
United States · Investor
Last cheque observed Jul 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.
QuietNew fund $117M, Sept 2016VC firm
Follow Avalon Ventures and see its new cheques in your feed.Start following
124 rounds on record
Mostly Series A and Series B: 70% of its rounds
Sole investor in 19 rounds, median $3.3M
19 exits from the portfolio
Avalon's long-standing and successful focus has been on seed and early stage companies, including many it formed in the life science and information technology sectors.From their own website
Every round we can evidence, newest first124 appearances
1 round
1 round
2 rounds
12 rounds
20 rounds
14 rounds
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
Named by the firm itself, on a filing, its Form ADV or its company registration12 named
We also hold 16 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
From the firm's own filings with the SEC, which it must file accurately by law
Companies it backed that were later bought or listed19 in all
An exit counts when it came after the firm's first round in the company. From historical deal records.
The investors most often in the same rounds as Avalon Ventures. A count of rooms they were both in, not a relationship either has claimed.
The latest companies Avalon Ventures put money into.
Avalon Ventures invests most often at Series A and Series B (70% of the rounds on record), in sectors such as Life Science and Information Technology.
124 investments on record, 0 of them in the last 12 months. The most recent was in Jul 2019.
Its most recent investments on record: Node (Undisclosed round, Jul 2019), Averon (Series A, Oct 2017) and Fortis Therapeutics (Series A, Sept 2016).
The median round it joins is $16M.
Rarely, if at all: none of its 124 investments on record names it as the lead.
Most of the companies it backs are in the United States (100%).
No investments in the last 12 months; the latest was in Jul 2019.
Most often Union Square Ventures (11 rounds together), Foundry Group (8 rounds together) and Correlation Ventures (7 rounds together).
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it